Becton Dickinson has obtained the CE-IVD mark on a combined panel assay to detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus. The assay runs on the firm's BD Max instrument and is now available in countries that recognize the CE mark, the firm said on Thursday.

Visby Medical said on Wednesday that it has added $35 million to its Series E financing round, bringing its total proceeds from the round to more than $135 million.

On June 28, the National Health Commission of the PRC released the "COVID-19 Prevention and Control Plan (Ninth Edition)". Compared with the eighth edition, the following revisions were made:

Roche announced on Tuesday that it has received CE marking for its Ventana DP 600 slide scanner for digital pathology.

Anitoa Systems announced on Wednesday that its PCR-based test for monkeypox has received CE marking.

As the grass-roots organization of CAST, Sansure Biotech attaches great importance to the construction of the enterprise association for science and technology, gives full play to the advantages of scientific and technological talents, innovation platforms, and good basic conditions.

Illumina said on Tuesday that it has invested an undisclosed amount in Time Boost Capital, a genomics venture fund that plans to match funding raised by startups participating in the UK-based version of Illumina's accelerator program.

Memorial Hermann Health System to launch a new population health program targeting 100,000 individuals.

Since Beckman Coulter began to develop in China more than 40 years ago, it has continued to increase local investment, firmly helped China's laboratory medicine, realized the localization of a number of products, and is committed to promoting leading science and technology to more people.

BforCure, a Paris-based point-of-care diagnostics firm, said on Monday it has received the CE-IVD mark for a PCR kit to detect influenza A, influenza B, and SARS-CoV-2.

Cepheid and BioGX announced on Monday a collaboration to develop a monkeypox assay on the GeneXpert system. Financial and other terms of the deal were not disclosed.

In the past two years, due to the strong cash flow driven by COVID-19, the industrial parks of Chinese IVD enterprises have been ready to land.

Illumina has acquired IDbyDNA, a company developing metagenomic technology for infectious disease testing and pathogen surveillance, GenomeWeb has learned today.

An analysis of monkeypox virus (MPXV) genomes from the ongoing global outbreak has found that the samples cluster together, indicating a single origin for them.

Recently, Shenzhen Eurekabio Technology Co., Ltd. (hereinafter referred to as "Eurekabio") announced that it had completed the 100 million CNY of round B financing.